Skip to main content
. 2019 Feb 16;20(4):856. doi: 10.3390/ijms20040856

Table 4.

Patient-reported outcome measures (pain: VAS and KOOS-pain; function: IKDC, WOMAC, KOOS: symptom, ADL, sport/recreation and QOL).

Control Group PRP Group
PROM MCID Mean Change Improved by at Least MCID [%] Mean Change Improved by at Least MCID [%] P a P b
VAS 2 [12] 2.36 ± 0.0.09 (3.86–5.20) 39 3.62 ± 0.07 (2.82–4.43) 65 0.027 0.046
IKDC 16.7 [13] 33.66 ± 0.84 (25.95–41.36) 83 34.74 ± 0.55 (28.17–41.31) 78 0.48 0.48
WOMAC 11.5 [14] 21.77 ± 0.67 (15.65–27.90) 65 24.77 ± 0.37 (20.40–29.14) 86 0.16 0.053
KOOS
Pain 16.7 [13] 24.95 ± 0.62 (19.24–30.66) 65 29.50 ± 0.45 (24.18–34.81) 73 0.17 0.36
Symptoms 17.4 [13] 18.38 ± 0.82 (10.81–25.95) 48 27.93 ± 0.42 (22.89–32.96) 76 0.016 0.028
ADL 18.4 [13] 24.61 ± 0.74 (17.79–31.43) 57 26.27 ± 0.39 (21.67–30.87) 76 0.18 0.1
S/R 12.5 [13] 43.75 ± 1.12 (33.43–54.07) 83 34.65 ± 0.76 (25.57–43.74) 70 0.12 0.22
QoL 15.6 [13] 32.67 ± 1.06 (22.93–42.41) 70 28.43 ± 0.52 (22.23–34.64) 76 0.29 0.41

a For mean changes; b for % of patients improved by at least MCID. Data are presented as mean ± standard error (CI 95%) unless otherwise indicated. PROM, patient related outcome measures; VAS, visual analogue scale; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index; IKDC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; ADL, activities of daily living; S/R, sport/recreation; QOL, quality of life; MCID, Minimal Clinically Important Difference.